📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis. (2019)

First Author: Chen YL

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.aax2945

PubMed Identifier: 31645451

Publication URI: http://europepmc.org/abstract/MED/31645451

Type: Journal Article/Review

Volume: 11

Parent Publication: Science translational medicine

Issue: 515

ISSN: 1946-6234